Mitsubishi UFJ Trust & Banking’s PTC Therapeutics PTCT Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.07M	Buy	+13,070	New	+$944K	﹤0.01%	833

Other funds holding PTCT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's PTCT Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking opened a new position in PTC Therapeutics (PTCT) in Q2 2026: 13,070 shares worth $1.07M. The stake represents ﹤0.01% of the portfolio and ranks #833 among its holdings.

382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

Mitsubishi UFJ Trust & Banking held 13,070 shares of PTC Therapeutics worth $1.07M as of Q2 2026.
PTC Therapeutics was a new Mitsubishi UFJ Trust & Banking position in Q2 2026.
PTC Therapeutics made up ﹤0.01% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #833 holding.
382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.